Damora Therapeutics, Inc.
DMRA
$24.16
$1.074.63%
NASDAQ
Corporate Info
Website
Phone Number
781 281 9020
Address
Building 23
Suite 105
221 Crescent Street
Waltham, MA 02453
Suite 105
221 Crescent Street
Waltham, MA 02453
Country
United States
Year Founded
2011
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.